1999
DOI: 10.1002/(sici)1520-6823(1999)7:1<1::aid-roi1>3.0.co;2-i
|View full text |Cite
|
Sign up to set email alerts
|

Molecular and anatomic considerations in the pathogenesis of breast cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2000
2000
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(3 citation statements)
references
References 49 publications
0
3
0
Order By: Relevance
“…Many studies relating molecular factors to breast cancer risk rely on end-point tumor analyses that make it challenging to dissociate tumor-initiating changes from byproducts of tumorigenesis (17,18). It is estimated that an individual cell requires the accumulation of 5 to 10 genetic or epigenetic events before neoplastic transformation occurs (19) and then another 10 to 15 years (in humans) for a neoplastically transformed cell to progress to a clinically detectable tumor (20). Due to the significant delays between cancer-predisposing events, cancer initiation, and cancer detection, the factors involved in cancer risk need to be assessed long before cancer diagnosis is possible.…”
Section: Introductionmentioning
confidence: 99%
“…Many studies relating molecular factors to breast cancer risk rely on end-point tumor analyses that make it challenging to dissociate tumor-initiating changes from byproducts of tumorigenesis (17,18). It is estimated that an individual cell requires the accumulation of 5 to 10 genetic or epigenetic events before neoplastic transformation occurs (19) and then another 10 to 15 years (in humans) for a neoplastically transformed cell to progress to a clinically detectable tumor (20). Due to the significant delays between cancer-predisposing events, cancer initiation, and cancer detection, the factors involved in cancer risk need to be assessed long before cancer diagnosis is possible.…”
Section: Introductionmentioning
confidence: 99%
“…In order to induce cells passing through unlimited proliferation, different kinds of methods have been explored. Carcinogenic agents ( 17 ), radiation ( 18 ) and even viral oncogenes ( 9 , 19 , 20 ) have been used to immortalize cells. However, carcinogenic agents like benzoapyrene (BaP) had tumorigenicity in nude mice, limiting its application ( 21 ).…”
Section: Discussionmentioning
confidence: 99%
“…It is estimated that about 40-60% breast cancer patients with early stage disease will undergo radiation treatment (36)(37)(38), However, development of radiation-induced secondary malignancy after successful radiotherapy of a prior cancer has been well documented. It is generally accepted among radiation oncologists that for most patients this is an unavoidable complication (39). However, for a specific population of patients, such as BRCA2 or BRCAl germline mutation carriers, the risk of radiation induced breast cancer warrants further investigation.…”
Section: Introductionmentioning
confidence: 99%